Nuwellis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuwellis and other ETFs, options, and stocks.

About NUWE

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. 

CEO
John L. Erb
CEOJohn L. Erb
Employees
38
Employees38
Headquarters
Eden Prairie, Minnesota
HeadquartersEden Prairie, Minnesota
Founded
1999
Founded1999
Employees
38
Employees38

NUWE Key Statistics

Market cap
3.13M
Market cap3.13M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
Dividend yield
Average volume
71.19K
Average volume71.19K
High today
High today
Low today
Low today
Open price
$1.77
Open price$1.77
Volume
0.00
Volume0.00
52 Week high
$25.95
52 Week high$25.95
52 Week low
$0.19
52 Week low$0.19

Stock Snapshot

The current Nuwellis(NUWE) stock price is $1.66, with a market capitalization of 3.13M. The stock trades at a price-to-earnings (P/E) ratio of -0.02.

On 2026-02-24, Nuwellis(NUWE) stock opened at $1.77, reached a high of —, and a low of —.

Nuwellis(NUWE) shares are trading with a volume of 0, against a daily average of 71.19K.

During the past year, Nuwellis(NUWE) stock moved between $0.19 at its lowest and $25.95 at its peak.

During the past year, Nuwellis(NUWE) stock moved between $0.19 at its lowest and $25.95 at its peak.

People also own

Based on the portfolios of people who own NUWE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.